AWM
PTX

Arbor Wealth Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Arbor Wealth Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40
Closed – – 134
2015
Q4 		$0 Buy
+40
New +$1.21K ﹤0.01% 138

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Arbor Wealth Management's PTX Position: Q1 2016 in Review

Arbor Wealth Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 40 shares.

Arbor Wealth Management first reported a position in PTX in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

  • Arbor Wealth Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
  • Arbor Wealth Management sold 40 Pernix Therapeutics Holdings, Inc. shares in Q1 2016.
  • Arbor Wealth Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2015 and held it in 1 quarter.
  • Arbor Wealth Management's Pernix Therapeutics Holdings, Inc. position peaked at $0 in Q4 2015.
  • 88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Arbor Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.